Machine learning based CAGIB score predicts in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding

Abstract Acute gastrointestinal bleeding (AGIB) is a potentially lethal complication in cirrhosis. In this prospective international multi-center study, the performance of CAGIB score for predicting the risk of in-hospital death in 2467 cirrhotic patients with AGIB was validated. Machine learning (M...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhaohui Bai, Su Lin, Mingyu Sun, Shanshan Yuan, Mariana Barros Marcondes, Dapeng Ma, Qiang Zhu, Yiling Li, Yingli He, Cyriac Abby Philips, Xiaofeng Liu, Kanokwan Pinyopornpanish, Lichun Shao, Nahum Méndez-Sánchez, Metin Basaranoglu, Yunhai Wu, Yu Chen, Ling Yang, Andrea Mancuso, Frank Tacke, Bimin Li, Lei Liu, Fanpu Ji, Xingshun Qi
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:npj Digital Medicine
Online Access:https://doi.org/10.1038/s41746-025-01883-w
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Acute gastrointestinal bleeding (AGIB) is a potentially lethal complication in cirrhosis. In this prospective international multi-center study, the performance of CAGIB score for predicting the risk of in-hospital death in 2467 cirrhotic patients with AGIB was validated. Machine learning (ML) models were established based on CAGIB components, and their area under curves (AUCs) were calculated and compared. Gray zone approach was employed to further stratify the risk of death. In training cohort, the AUC of CAGIB score was 0.789. Among the ML models, the least square support vector machine regression (LS-SVMR) model had the best predictive performance (AUC = 0.986). Patients were further divided into low- (LS-SVMR score <0.084), moderate- (LS-SVMR score 0.084–0.160), and high-risk (LS-SVMR score >0.160) groups with in-hospital mortality of 0.38%, 2.22%, and 64.37%, respectively. Statistical results were retained in validation cohort. LS-SVMR model has an excellent predictive performance for in-hospital death in cirrhotic patients with AGIB (ClinicalTrials.gov; NCT04662918).
ISSN:2398-6352